The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target (2019) Brandl L, Kirstein N, Neumann J, Sendelhofert A, Vieth M, Kirchner T, Menssen A Journal article Primary leiomyosarcoma of the skin: a comprehensive review on diagnosis and treatment (2018) Zacher M, Heppt MV, Brinker TJ, Hayani KM, Flaig MJ, Berking C Journal article, Review article MGMT promoter methylation is not correlated with integrin expression in malignant gliomas: clarifying recent clinical trial results (2018) Schnell O, Albrecht V, Pfirrmann D, Eigenbrod S, Krebs B, Romagna A, Siller S, et al. Journal article Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial (2017) Walter I, Schulz U, Vogelhuber M, Wiedmann K, Endlicher E, Klebl F, Andreesen R, et al. Journal article Prognostic impact of PD-1 and its ligands in renal cell carcinoma (2017) Erlmeier F, Weichert W, Schrader AJ, Autenrieth M, Hartmann A, Steffens S, Ivanyi P Journal article PD-L2: A prognostic marker in chromophobe renal cell carcinoma? (2017) Erlmeier F, Weichert W, Autenrieth M, Wiedemann M, Schrader AJ, Hartmann A, Ivanyi P, Steffens S Journal article c-Met in chromophobe renal cell carcinoma (2017) Erlmeier F, Ivanyi P, Hartmann A, Autenrieth M, Wiedemann M, Weichert W, Steffens S Journal article PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception? (2016) Erlmeier F, Hartmann A, Autenrieth M, Wiedemann M, Ivanyi P, Steffens S, Weichert W Journal article Analysis of a case with disappearance of the primary gastrointestinal stromal tumor and progressive liver metastases under long-term treatment with tyrosine kinase inhibitors (2010) Cameron S, Savvoukidis T, Armbrust T, Haller F, Kitz J, Füzesi L, Ramadori G Journal article